Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Indomethacin-induced hyperkalaemia.

E P MacCarthy, G W Frost, G S Strokes

    The Medical Journal of Australia
    |June 16, 1979
    PubMed
    Summary
    This summary is machine-generated.

    Indomethacin therapy can cause dangerous hyperkalemia in patients with chronic kidney disease. Discontinuing the drug reversed the condition, suggesting a drug-induced defect in cellular potassium uptake.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Snake-Poisoning in the Hills (7,400 Ft.).

    The Indian medical gazette·2017
    Same author

    Vaccine-preventable childhood diseases in Australia.

    The Medical journal of Australia·1996
    Same author

    The efficacy and safety of once-daily nifedipine: the coat-core formulation compared with the gastrointestinal therapeutic system formulation in patients with mild-to-moderate diastolic hypertension. Nifedipine Study Group.

    Clinical therapeutics·1995
    Same author

    The ABCD (Appropriate Blood Pressure Control in Diabetes) trial. Rationale and design of a trial of hypertension control (moderate or intensive) in type II diabetes.

    The Online journal of current clinical trials·1993
    Same author

    Effectiveness of once-daily monotherapy with a new nifedipine sustained release calcium antagonist.

    The American journal of cardiology·1992
    Same author

    A comparison of the safety of therapeutically equivalent doses of isradipine and diltiazem for treatment of essential hypertension.

    American journal of hypertension·1992
    Same journal

    Drivers of Vaccine Uptake for Aboriginal and Torres Strait Islander Children to Inform Tailored Strategies: A Qualitative Study Exploring Health Service Provider Perspective.

    The Medical journal of Australia·2026
    Same journal

    Four Urgent Actions for the Rights to Culturally Safe Breastfeeding for Aboriginal and Torres Strait Islander Mothers and Babies to Breastfeed in Neonatal Intensive Care Environments.

    The Medical journal of Australia·2026
    Same journal

    Intergenerational Child Protection Contact and Child Development Outcomes: A Whole Population Linked Data Study.

    The Medical journal of Australia·2026
    Same journal

    Treatment and Survival Outcomes for Indigenous and Non-Indigenous Australians Within the Victorian Lung Cancer Registry: A Retrospective Cross-Sectional Cohort Study.

    The Medical journal of Australia·2026
    Same journal

    Worsening Asthma Outcomes in Australian Adults: A Comparison of Stratified Sample Surveys in 2012 and 2021.

    The Medical journal of Australia·2026
    Same journal

    Stigmatising Attitudes Towards People With Depression, Bipolar Disorder, Borderline Personality, ADHD and Early and Long-Term/Untreated Schizophrenia: Representative Survey of Australian Adults.

    The Medical journal of Australia·2026
    See all related articles

    Area of Science:

    • Nephrology
    • Pharmacology
    • Internal Medicine

    Background:

    • Chronic renal failure (CRF) patients are susceptible to electrolyte disturbances.
    • Nonsteroidal anti-inflammatory drugs (NSAIDs) like indomethacin can affect renal function and potassium homeostasis.

    Observation:

    • A patient with mild CRF experienced severe hyperkalemia during indomethacin treatment.
    • The hyperkalemia resolved after the cessation of indomethacin therapy.

    Findings:

    • Indomethacin induced a significant defect in cellular potassium uptake.
    • This drug-induced defect led to hyperkalemia in the context of impaired renal function.

    Implications:

    • Clinicians should monitor potassium levels in CRF patients receiving indomethacin.

    Related Experiment Videos

  • Understanding NSAID-induced hyperkalemia mechanisms is crucial for patient safety.
  • Alternative pain management strategies may be necessary for patients with CRF on NSAIDs.